Safety Phase Of Novel UM Stem Cell Trial Completed
Physicians at the University of Miami Miller School of Medicine’s Interdisciplinary Stem Cell Institute have successfully completed the first safety phase of a novel trial using stem cell injections into the heart muscle for patients who have had a prior heart attack. With this milestone, the study’s independent Data Safety Monitoring Board has given approval for the UM team to begin the next phase of their study.
[Read the full article here]Related News:
Stem Cell Therapeutics Corp. Announces Positive Review By Data Safety And Monitoring Board For The Phase IIb Stroke …
DSMB recommends continuation of Stem Cell Therapeutics’ phase-IIb stroke trial
DSMB recommends Stem Cell Therapeutics for phase-IIb acute ischemic stroke trial